| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1381615B1 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- [1,4]DIOXINO[2,3-e]INDOLE |
| 10/13/2004 | EP1381613B1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-(1,4)-benzodioxans |
| 10/13/2004 | EP1251133B1 Novel carbapenem derivatives |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803368 Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene |
| 10/07/2004 | WO2004085421A2 Bioreductively-activated prodrugs |
| 10/07/2004 | WO2004013297A3 Manzamine-producing actinomycetes |
| 10/07/2004 | WO2003076446A8 Antiparasitic artemisinin derivatives (endoperoxides) |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | US20040198755 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 10/07/2004 | US20040198737 Azaindoles |
| 10/07/2004 | US20040198719 Antagonist of MCP-1 function, and compositions and methods of use thereof |
| 10/07/2004 | US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | CA2519901A1 Bioreductively-activated prodrugs |
| 10/06/2004 | EP1463733A2 Mitotic kinesin inhibitors |
| 10/06/2004 | EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | CN1535274A Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1534038A High effect production method of catharanthine |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800640 Antiserotonine agents; central nervous system disorders |
| 10/05/2004 | US6800621 Imidazo[4,5-b]-pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum activity |
| 09/30/2004 | WO2004083175A2 Methods for identifying enzyme inhibitors and protein kinases |
| 09/30/2004 | US20040192885 Novel non-natural C-linked carbo-beta-peptides with robust secondary structures |
| 09/30/2004 | US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents |
| 09/30/2004 | US20040192679 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof |
| 09/30/2004 | US20040192678 Pyrrolo[2,1-c][1,4] benzodiazepines compounds and process thereof |
| 09/30/2004 | US20040191796 8-(3-{[bis(methylethyl)amino](2-cyanoethoxy)phosphinooxy}propyl)- 7-oxophenoxazin-3-yl 2,2-dimethylpropanoate; improves signal to noise ratios and other advantageous characteristics in hybridization and related assays |
| 09/29/2004 | EP1461339A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/29/2004 | EP1461335A1 2-heteroarylcarboxylic acid amides |
| 09/29/2004 | EP1392700B1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/23/2004 | WO2004081011A1 Immunomodulating heterocyclic compounds |
| 09/23/2004 | WO2004064721A3 A pyrazolopyrimidine compound and a process for preparing the same |
| 09/23/2004 | WO2004039815A8 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| 09/23/2004 | WO2003103574A3 Protease inhibitors |
| 09/23/2004 | US20040186286 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186129 2-Aroylimidazole compounds for treating cancer |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186123 such as 2[(Benzyloxy)methyl]-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinoline; serotonin receptor antagonists for treatment of depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety disorders, sexual dysfunction, and eating disorders |
| 09/22/2004 | EP1458726A2 Mitotic kinesin inhibitors |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | CN1531444A Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same |
| 09/21/2004 | US6794509 Compounds for fluorescence labeling |
| 09/16/2004 | WO2004078762A1 Deoxoartemisinin analogs, process for their preparation, and anticancer agent comprising them |
| 09/16/2004 | WO2004078110A2 Fused imizadoles as transforming growth factor (tgf) inhibitors |
| 09/16/2004 | WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 09/16/2004 | WO2004058176A3 Acyclic pyrazole compounds |
| 09/16/2004 | WO2003105666A3 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/16/2004 | WO2003092586A3 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 09/16/2004 | DE10309927A1 New trisubstituted dihydro-imidazo-pyridazinone or imidazo-pyridinone derivatives, useful as dipeptidylpeptidase-IV inhibitors for e.g. treating diabetes mellitus type I or II, arthritis or obesity |
| 09/15/2004 | EP1456206A1 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/15/2004 | CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/14/2004 | US6790945 Fluorescent quenching detection reagents and methods |
| 09/14/2004 | US6790863 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents |
| 09/10/2004 | WO2004076455A1 Spiro-substituted pyrrolopyrimidines |
| 09/10/2004 | WO2004076454A1 Dihydropteridinones, method for the production and use thereof in the form of drugs |
| 09/10/2004 | CA2517035A1 Spiro-substituted pyrrolopyrimidines |
| 09/09/2004 | US20040176390 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors |
| 09/09/2004 | US20040176380 Antiproliferative agents; specific cell cycle kinases inhibitors |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040175638 Simple synthesis; high charge mobility; close packed, stable morphology; thin films; ordered mesogenic, crosslinkable monomers |
| 09/08/2004 | EP1453831A1 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | CN1527831A Antagonists of MCP-q function and method of use thereof |
| 09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 09/07/2004 | US6787541 Thieno-and furopyrimidine derivatives as A2A-receptor antagonists |
| 09/02/2004 | WO2004050036A3 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 09/02/2004 | US20040171672 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 09/02/2004 | US20040171623 thieno[2,3-d]pyrimidinediones; modulation of autoimmune disease |
| 09/02/2004 | US20040171620 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 09/02/2004 | US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 09/02/2004 | US20040170980 Molecules capable of binding to telomere and the like and method with the use of the same |
| 09/02/2004 | US20040170863 Organic electroluminescent devices using double-spiro organic compounds |
| 09/01/2004 | EP1451197A1 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo- 3.2.2 nonane derivatives, preparation and therapeutic use thereof |
| 09/01/2004 | EP1451196A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/01/2004 | EP1451161A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands |
| 09/01/2004 | EP1450811A2 2-aryl pyrrolopyrimidines for a1 and a3 receptors |
| 08/31/2004 | US6784190 Integrin receptor antagonists |
| 08/26/2004 | US20040167198 Vasculostatic agents and methods of use thereof |
| 08/26/2004 | US20040167156 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
| 08/26/2004 | US20040167123 Anti-infective agents |
| 08/26/2004 | US20040166441 Optical information-recording medium, novel oxonol compound and method of recording information |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1366048B1 Pyrazolopyridine derivatives |
| 08/25/2004 | CN1163502C Novel A1 adenosine receptor incitant |